Junshi Biosciences Appoints Wei Qian as Chief Commerical Officer

SHANGHAI, China, July 2 (Korea Bizwire) – Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the company has appointed Mr. Wei Qian as Chief Commercial Officer (CCO). Mr. Qian will be responsible for the company’s commercialization planning and operations. [...]